Sort
146,196 grants matching “diabetes”
Cadiorenal and Metabolic Diseases Research Center
$2,276,985John E Hall · University Of Mississippi Med Ctr · P20 · FY2017 · GM
West Virginia University Stroke COBRE
$2,276,620Anne Courtney Devries · West Virginia University · P20 · FY2022 · GM
West Virginia University Stroke COBRE
$2,276,620Anne Courtney Devries · West Virginia University · P20 · FY2023 · GM
West Virginia University Stroke COBRE
$2,276,620Anne Courtney Devries · West Virginia University · P20 · FY2020 · GM
West Virginia University Stroke COBRE
$2,276,620Anne Courtney Devries · West Virginia University · P20 · FY2021 · GM
PREVENTABLE Data Coordinating Center
$2,276,326Bradley G Hammill · Duke University · U19 · FY2025 · AG
Institute for Biomedical and Health Disparities Research
$2,275,641Texas Southern University · G12 · FY2004 · RR
RFA-DP-19-001, Health Promotion and Disease Prevention Research Centers
$2,275,000Alice S. Ammerman · Univ Of North Carolina Chapel Hill · U48 · FY2023 · DP
Air Pollution, Metabolome, and Alzheimer disease in Mexican Americans
$2,274,447Beate R Ritz · University Of California Los Angeles · RF1 · FY2022 · NS
Hepatobiology and Toxicology COBRE
$2,274,291Craig J McClain · University Of Louisville · P20 · FY2023 · GM
Membrane-Mediated Alterations in Diabetes
$2,273,670Richard W Gross · Washington University · P01 · FY2008 · HL
Defining Mechanisms Controlling Stem Cell Fate During Differentiation
$2,272,500Ipsita Banerjee · University Of Pittsburgh At Pittsburgh · DP2 · FY2009 · OD
Preclinical drug development in pancreatic cancer
$2,272,436Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Identifying the gene networks of insulin resistance: the GENESIPS study
$2,272,407Thomas None Quertermous · Stanford University · U01 · FY2015 · HL
Pyruvate kinase M2 levels and activation as protective factors for diabetic nephropathy
$2,272,183George L King · Joslin Diabetes Center · DP3 · FY2016 · DK
Non-alcoholic Fatty Liver Disease and Cardiovascular Disease in Hispanics/Latinos
$2,271,824Jorge R Kizer · Northern California Institute/Res/Edu · R01 · FY2022 · HL
Development of inhibitors of AMP Deaminase Isoform 2 as a Mechanism for Treating
$2,271,441Richard Joseph Johnson · University Of Colorado Denver · RC4 · FY2010 · DK
Autophagy, Inflammation and Metabolism (AIM) in Disease Center - Phase 2.
$2,270,783Vojo P Deretic · University Of New Mexico Health Scis Ctr · P20 · FY2023 · GM
Illuminating Function of the Understudied Druggable Kinome
$2,270,717Gary L. Johnson · Univ Of North Carolina Chapel Hill · U24 · FY2018 · DK
Sleep, Aging and Circadian Rhythm Disorders
$2,270,035Charles A Czeisler · Brigham And Women'S Hospital · P01 · FY2016 · AG
Clinic, Family & Community Collaboration to Treat Overweight and Obese Children
$2,269,982Thomas N Robinson · Stanford University · U01 · FY2015 · HL
NICHD Maternal Fetal Medicine Units Network
$2,269,438Kenneth J. Leveno · Ut Southwestern Medical Center · U10 · FY2007 · HD
ETIB Clinical Research Core
$2,268,710Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2013 · CA
CCR Office of Training and Education
$2,268,673Jonathan Scott Wiest · Division Of Basic Sciences - Nci · ZIJ · FY2009 · CA
Genes, environmental stressors, and the biobehavioral pathways to CVD
$2,268,585Redford B Williams · Duke University · P01 · FY2011 · HL